NovaBay Pharmaceuticals, Inc.
NBY
$0.6001
$0.00010.02%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.22M | -10.12M | -10.66M | -11.12M | -9.64M |
| Total Depreciation and Amortization | 381.00K | 381.00K | 381.00K | 355.00K | 356.00K |
| Total Amortization of Deferred Charges | 874.00K | 1.44M | 1.96M | 2.11M | 1.69M |
| Total Other Non-Cash Items | 1.17M | 3.60M | 4.32M | 4.30M | 3.39M |
| Change in Net Operating Assets | -595.00K | -534.00K | 465.00K | -446.00K | -433.00K |
| Cash from Operations | -5.39M | -5.23M | -3.54M | -4.80M | -4.63M |
| Capital Expenditure | -6.00K | -9.00K | -8.00K | -8.00K | -19.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 1.07M | 1.07M | 1.07M | 1.07M | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.06M | 1.06M | 1.06M | 1.06M | -19.00K |
| Total Debt Issued | 500.00K | 0.00 | 0.00 | 3.00M | 3.00M |
| Total Debt Repaid | -1.99M | -2.69M | -2.48M | -2.05M | -1.47M |
| Issuance of Common Stock | 3.11M | 3.67M | 791.00K | 565.00K | 565.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.00K | -2.00K | -2.00K | -200.00K | -181.00K |
| Cash from Financing | 1.50M | 974.00K | -1.69M | 1.31M | 1.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 126.00K | 590.00K | 313.00K | 297.00K | 297.00K |
| Net Change in Cash | -2.70M | -2.61M | -3.85M | -2.13M | -2.45M |